紫外吸収過渡吸収顕微鏡によるラベルフリー・固定化フリーのタンパク質結合アッセイ
Jianghao Shen1, Qiangqiang Wang2, Fan Wu1
1Institute of Medical Photonics, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 27, 2026
まとめ
UV-TAM(紫外線過渡吸収顕微鏡)を開発し、タンパク質-リガンド相互作用の研究にラベルフリーで利用した。この手法は溶液中の結合を直接検出し、創薬のための新しいツールを提供する。
科学分野:
- 生化学
- 生物物理学
- 分析化学
背景:
- タンパク質-リガンド相互作用は、生物学的プロセスおよび創薬において重要である。
- これらの相互作用を研究するための従来の多くの方法は、天然の結合挙動を妨げる可能性のある標識化または固定化を必要とする。
研究 の 目的:
- UV-TAM(紫外線過渡吸収顕微鏡)を、溶液中のタンパク質-リガンド相互作用を研究するための新しいラベルフリー技術として導入する。
- UV-TAMの結合イベントのリアルタイム検出および定量的解析への有用性を実証する。
主な方法:
- 励起にはフェムト秒深紫外レーザーパルスを使用し、モニタリングには近紫外プローブビームを使用して、トリプトファン残基の励起状態ダイナミクスの変化を監視した。
- UV-TAMを用いて、マイクロリットルスケールのサンプル量で、タンパク質-リガンド結合のラベルフリー、溶液中測定を行った。
- この技術を、血漿タンパク質(ウシ血清アルブミン、ヘモグロビン)とアルカロイドリガンド(ベルベリン、パルマチン)との相互作用の研究に適用した。
主要な成果:
- UV-TAMは、リガンド誘発性の時間分解スペクトルダイナミクスの変化を通じて、結合イベントを検出し成功した。
- ヘモグロビン-アルカロイド相互作用の定量的解析により、等温滴定熱量測定で得られたものと密接に一致する解離定数が得られた。
- UV-TAM技術のラベルフリーおよび溶液中での能力を実証した。
結論:
- UV-TAMは、溶液中のタンパク質-リガンド相互作用の直接検出および定量化のための、堅牢でキャリブレーションフリーのプラットフォームを提供する。
- この技術は、生化学研究の進歩およびハイスループット創薬スクリーニングの促進に大きな可能性を示す。
関連する概念動画
Protein Absorption
981
Proteins in the gastrointestinal tract typically come from food, but they can also originate from disintegrated cells or secreted enzymes. In the stomach, the enzyme pepsin breaks down these proteins into polypeptides. The fragments then move into the duodenum as a semi-fluid mass called chyme. Pancreatic proteases, such as trypsin and chymotrypsin, and intestinal brush border enzymes like carboxypeptidases further dismantle the polypeptides into tripeptides, dipeptides, and free amino acids.
981
Factors Affecting Protein-Drug Binding: Protein-Related Factors
547
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
547
The Equilibrium Binding Constant and Binding Strength
15.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Protein-Drug Binding: Determination Methods
646
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
646
Drug Distribution: Plasma Protein Binding
8.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K
Protein-Drug Binding: Mechanism and Kinetics
1.8K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.8K


